Opko Health (OPK) Income from Continuing Operations (2010 - 2026)
Opko Health (OPK) reported Income from Continuing Operations of 54846000.0 for Q1 2026, up 18.87% on a YoY basis from 46138834.08 in Q1 2025, and down 18.61% quarter-over-quarter from 46239000.0 in Q4 2025.
Opko Health (OPK) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Opko Health has reported Income from Continuing Operations for 17 years, with the latest figure at 54846000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 18.87% year-over-year to 54846000.0; the trailing twelve-month figure through Mar 2026 stood at 227892000.0 (down 69.0% YoY), and the FY2025 full-year result was 240650000.0, down 525.68% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 54846000.0, down from 46239000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 24893000.0 in Q3 2024, with the low at 159612000.0 in Q4 2022.
- Historically, Income from Continuing Operations has averaged 59620125.0 across 5 years, with a median of 60929500.0 in 2022.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations jumped 129.48% — and 2025, when it slumped 1340.62%.
- Opko Health's Income from Continuing Operations stood at 159612000.0 in 2022, then jumped by 58.35% to 66475000.0 in 2023, then jumped by 137.45% to 24893000.0 in 2024, then plunged by 285.75% to 46239000.0 in 2025, then slipped by 18.61% to 54846000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 54846000.0 (Q1 2026), 46239000.0 (Q4 2025), and 21634000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 269.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Opko Health | 1.09 Bn | 747.11 Mn | 45.76 Mn | -54.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -54.85 Mn |
| Dec 31, 2025 | -46.24 Mn |
| Sep 30, 2025 | 21.63 Mn |
| Jun 30, 2025 | -148.44 Mn |
| Mar 31, 2025 | -67.60 Mn |
| Sep 30, 2024 | 24.89 Mn |
| Jun 30, 2024 | -10.30 Mn |
| Mar 31, 2024 | -81.83 Mn |
| Dec 31, 2023 | -66.48 Mn |
| Sep 30, 2023 | -84.45 Mn |
| Jun 30, 2023 | -19.60 Mn |
| Mar 31, 2023 | -18.23 Mn |
| Dec 31, 2022 | -159.61 Mn |
| Sep 30, 2022 | -86.05 Mn |
| Jun 30, 2022 | -101.38 Mn |
| Mar 31, 2022 | -55.38 Mn |
| Dec 31, 2021 | -63.15 Mn |
| Sep 30, 2021 | 28.79 Mn |
| Jun 30, 2021 | -16.12 Mn |
| Mar 31, 2021 | 31.12 Mn |